article thumbnail

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

Health Populi

The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. The FDA regulatory process and aftermath. consumers’ bipartisan support for drug price regulation through Medicare negotiation and private/commercial sector adoption.

article thumbnail

Our Homes Are Health Delivery Platforms – The New Home Health/Care at CES 2021

Health Populi

The public health crisis, combined with Medicare Advantage and other payors’ regimes, supported an economic model for the hospital-to-home movement. Even before the COVID-19 pandemic, more hospitals were piloting and planning to move inpatient acute care to certain patients’ home when that made clinical and economic sense.

article thumbnail

Thank Ketamine for the Telehealth Extension

Bill of Health

Note: FDA approval for at least one indication is necessary for other “off-label” uses of the drug. You need one FDA approval to open the door to other off-label uses. Remember — no other psychedelic is FDA-approved ( yet ). However, the U.S. none can ( legally ) provide psilocybin, LSD, or MDMA ( yet ).

FDA 111